Hemlibra® (emicizumab)
for Hemophilia

Hemlibra (emicizumab) is a monoclonal antibody used to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A, with or without factor VIII inhibitors. It functions as a bridge between clotting factors to replace missing factor VIII, improving blood clotting. Hemlibra is not used to stop active bleeding once it has started.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hemophilia